Annals of Oncology

In this issue:

In this issue
Ann Oncol 5: 1.
[PDF] [Request Permissions]

Contents of the next issue:

Contents of the next issue
Ann Oncol 5: 1.
[PDF] [Request Permissions]

News:

Waiting time for cancer patients in the U.K.: Not a problem in medical oncology
Ann Oncol 5: 2.
[PDF] [Request Permissions]

EO9 to be licensed by Kyowa Hakko Kogyo
Ann Oncol 5: 2.
[PDF] [Request Permissions]

National Cancer Institute of Canada Clinical Trials Group
Ann Oncol 5: 2-6.
[PDF] [Request Permissions]

World Bank self-criticism on health matters
Ann Oncol 5: 4.
[PDF] [Request Permissions]

Agent Orange and Seveso: No end in sight
Ann Oncol 5: 4.
[PDF] [Request Permissions]

Euthanasia in Japan: Mixed feelings
Ann Oncol 5: 5.
[PDF] [Request Permissions]

Corrigendum
Ann Oncol 5: 5.
[PDF] [Request Permissions]

Perhaps not everyone knows that...
Ann Oncol 5: 5-6.
[PDF] [Request Permissions]

Editorials:

Franco Cavalli

A new year, a few changes
Ann Oncol 5: 7.
[PDF] [Request Permissions]

G. Cocconi

Chemotherapy of advanced gastric carcinoma: To be completely rewritten?
Ann Oncol 5: 8-11.
[PDF] [Request Permissions]

Special articles:

I. G. Finlay and R. Dunlop

Quality of life assessment in palliative care
Ann Oncol 5: 13-18.
[PDF] [Request Permissions]

Commentary:

B. Coiffier, T. Philip, A. K. Burnett, and M. L Symann

Consensus conference on intensive chemotherapy plus hematopoietic stem cell transplantation in malignancies, Lyon, June 4–6, 1993
Ann Oncol 5: 19-23.
[PDF] [Request Permissions]

Arena:

W. Sauerbrei and W. Jäger

Timing of breast cancer surgery — some arguments that there is no effect
Ann Oncol 5: 25-27.
[PDF] [Request Permissions]

R. A. Badwe and R. R. Juvekar

Timing of breast cancer surgery during the menstrual cycle
Ann Oncol 5: 29-31.
[PDF] [Request Permissions]

Original articles:

R. C. Coombes, C. E. D. Chilvers, D. Amadori, F Medi, G. Fountzilas, H. Rauschecker, P. Vassilopoulos, E. Pinto Ferreira, G. Vannozzi, J. M. Bliss, E. Woods, and J. Wils

Randomised trial of epirubicin versus fluorouracil in advanced gastric cancer: An International Collaborative Cancer Group (ICCG) study
Ann Oncol 5: 33-36.
[Abstract] [PDF] [Request Permissions]

A. Depierre, Cl. Chastang, E. Quoix, B. Lebeau, F. Blachon, N. Paillot, E. Lemarie, B. Milleron, D. Moro, J. Clavier, D. Herman, E Tuchais, P. Jacoulet, J. M Brechot, J. F. Cordier, p. Solal-Celigny, N. Badri, and M. Besenval

Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: A randomized trial
Ann Oncol 5: 37-42.
[Abstract] [PDF] [Request Permissions]

C. K. Osborne, M.C Sunderland, J.A. Neidhart, P.M. Ravdin, and M.D. Abeloff

Failure of GM-CSF to permit dose-escalation in an every other week dose-intensive regimen for advanced breast cancer
Ann Oncol 5: 43-47.
[Abstract] [PDF] [Request Permissions]

H. Koppler, K.-H. Pfluger, I. Eschenbach, R. Pfab, J. Birkmann, W. Zeller, R. Holle, U. E. Steinhauer, C. Gropp, S. Oehl, K. Lennert, M. R. Parwaresch, H. Kuhn, P. Drings, H. H. Gossmann, M. Khoury, R. Schubotz, and K. Havemann

Randomised comparison of CHOEP versus alternating hCHOP/IVEP for high-grade non-Hodgkin's lymphomas: Treatment results and prognostic factor analysis in a multi-centre trial
Ann Oncol 5: 49-55.
[Abstract] [PDF] [Request Permissions]

D. C. Betticher, M. F Fey, A. von Rohr, A. Tobler, H. Jenzer, A. Gratwohl, A. Lohri, P. Pugin, U. Hess, O. Pagani, G. Zulian, and T. Cerny

High incidence of infections after 2-chlorodeoxyadenosine (2-CDA) therapy in patients with malignant lymphomas and chronic and acute leukaemias
Ann Oncol 5: 57-64.
[Abstract] [PDF] [Request Permissions]

C. Huirny, J. Bernhard, A. Coates, M. Castiglione, H. F Peterson, R. D. Gelber, C.-M. Rudenstam, A. Goldhirsch, and H.-J. Senn

Timing of baseline quality of life assessment in an international adjuvant breast cancer trial: Its effect on patient self-estimation
Ann Oncol 5: 65-74.
[Abstract] [PDF] [Request Permissions]

A. G. J. van der Zee, E. G. E. de Vries, H. Hollema, S. B. Kaye, R. Brown, and W N. Keith

Molecular analysis of the topoisomerase II gene and its expression in human ovarian cancer
Ann Oncol 5: 75-81.
[Abstract] [PDF] [Request Permissions]

Book reviews:

Book review
Ann Oncol 5: 42.
[PDF] [Request Permissions]

Martin F. Fey

Book review
Ann Oncol 5: 74.
[PDF] [Request Permissions]

S. Leyvraz

Book review
Ann Oncol 5: 89.
[PDF] [Request Permissions]

Clinical case:

I. Besznyák and S. Eckhardt

Male breast cancer
Ann Oncol 5: 83-85.
[PDF] [Request Permissions]

Short reports:

E. Au and P.-T. Ang

A phase II trial of 5-fluorouracil and cisplatinum in recurrent or metastatic nasopharyngeal carcinoma
Ann Oncol 5: 87-89.
[Abstract] [PDF] [Request Permissions]

B. G. Taal, F G. M. Teller, W. W. ten Bokkel Huinink, H. Boot, J.H. Beijnen, and R. Dubbelman

Etoposide, leucovorin, 5-fluorouracil (ELF) combination chemotherapy for advanced gastric cancer: Experience with two treatment schedules incorporating intravenous or oral etoposide
Ann Oncol 5: 90-92.
[Abstract] [PDF] [Request Permissions]

G. Bisagni, G. Cocconi, Di Blasio, G. Ceci, V. De Lisi, C. Finardi, R. Lottici, and R Passalacqua

M-VAC combination in locally advanced, locally recurrent or metastatic breast carcinoma. A phase II study
Ann Oncol 5: 93-94.
[Abstract] [PDF] [Request Permissions]

G. Catimel, F Chauvin, J. P. Guastalla, P. Rebattu, P. Biron, and M. Clavelt

FAC (fluorouracil, doxorubicin, cyclophosphamide) as second line chemotherapy in patients with metastatic breast cancer progressing under FEC (fluorouracil, epirubicin, cyclophosphamide) chemotherapy
Ann Oncol 5: 95-97.
[Abstract] [PDF] [Request Permissions]

Letters:

A. M. Childs, A. S. Coates, K. M. Cox, and P. N. Mainwaring

Severe vascular adverse effects with thrombocytopenia and renal failure following emetogenic chemotherapy and ondansetron
Ann Oncol 5: 98.
[PDF] [Request Permissions]

N. A. Dobbs and C.J. Twelves

Comments on epirubicin
Ann Oncol 5: 98-99.
[PDF] [Request Permissions]

L. Gianni and G. bonadonna

The above letter was referred to the authors who respond as follows:
Ann Oncol 5: 99.
[PDF] [Request Permissions]

Advertisements in this issue:

Advertisements in this issue
Ann Oncol 5: 100-104.
[PDF] [Request Permissions]

Instructions to Authors:

Instruction to authors
Ann Oncol 5: 101-102.
[PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.